WP1130 Enhances TRAIL-Induced Apoptosis through USP9X-Dependent miR-708-Mediated Downregulation of c-FLIP.

Cancers (Basel) 2019 Mar 11;11(3). Epub 2019 Mar 11.

Department of Immunology, School of Medicine, Keimyung University, 1095 Dalgubeoldaero, Dalseo-Gu, Daegu 42601, Korea.

WP1130, a partially selective deubiquitinases (DUB) inhibitor, inhibits the deubiquitinating activities of USP5, USP9X, USP14, USP37, and UCHL1. In this study, we investigate whether WP1130 exerts sensitizing effect on TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human renal carcinoma cells. Combinations of WP1130 and TRAIL significantly induced apoptosis in renal carcinoma, lung carcinoma and hepatocellular carcinoma cells, but not in normal cells (human mesangial cells (MC) and normal mouse kidney cells (TCMK-1)). The downregulation of c-FLIP protein expression was involved in combined treatment-induced apoptosis. WP1130-induced c-FLIP downregulation was regulated by microRNA (miR)-708 upregulation via inhibition of USP9X. Interestingly, knockdown of USP9X markedly induced c-FLIP downregulation, upregulation of miR-708 expression and sensitivity to TRAIL. Furthermore, ectopic expression of USP9X prevented c-FLIP downregulation and apoptosis upon combined treatment. In sum, WP1130 sensitized TRAIL-induced apoptosis through miR-708-mediated downregulation of c-FLIP by inhibition of USP9X.

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11030344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469024PMC
March 2019

Publication Analysis

Top Keywords

trail-induced apoptosis
12
c-flip downregulation
12
downregulation c-flip
12
carcinoma cells
8
renal carcinoma
8
inhibition usp9x
8
cells normal
8
mir-708-mediated downregulation
8
c-flip
6
downregulation
6
apoptosis
6
usp9x
5
cells
5
wp1130
5
upregulation mir-708
4
hepatocellular carcinoma
4
normal cells
4
carcinoma hepatocellular
4
mir-708 expression
4
human mesangial
4

Similar Publications